Subscribe

Jonathan Wesley Riess, MD, MS

Medical Director of Thoracic Oncology
Associate Professor, Hematology and Oncology
University of California
UC Davis Comprehensive Cancer Center
Sacramento, CA

Authored Items

Best Practices: Practical Guidance in Treating Advanced NSCLC with Immunotherapy
By Jonathan Wesley Riess, MD, MS
Supplements
NSCLC
Lung cancer is the second-most common type of cancer in the United States, including approximately 235,000 new cases each year, 84% of which are non–small-cell lung cancer (NSCLC).

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, monthly TON print publication and TON weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.